Hydrogen gas improves photothermal therapy of tumor and restrains the relapse of distant dormant tumor
Read more:
DOI:
10.1016/j.biomaterials.2019.119472
DOI is the universal ID for this study.
This link will take you to the full study.
Abstract:
Inflammation during photothermal therapy (PTT) of tumor usually results in adverse consequences. Here, a biomembrane camouflaged nanomedicine (mPDAB) containing polydopamine and ammonia borane was designed to enhance PTT efficacy and mitigate inflammation. Polydopamine, a biocompatible photothermal agent, can effectively convert light into heat for PTT. Ammonia borane was linked to the surface of polydopamine through the interaction of hydrogen bonding, which could destroy redox homoeostasis in tumor cells and reduce inflammation by H2 release in tumor microenvironment. Owing to the same origin of outer biomembranes, mPDAB showed excellent tumor accumulation and low systemic toxicity in a breast tumor model. Excellent PTT efficacy and inflammation reduction made the mPDAB completely eliminate the primary tumors, while also restraining the outgrowth of distant dormant tumors. The biomimetic nanomedicine shows potentials as a universal inflammation-self-alleviated platform to ameliorate inflammation-related disease treatment, including but not limited to PTT for tumor.| Publish Year | 2019 |
|---|---|
| Country | China |
| Rank | Positive |
| Journal | Biomaterials |
| Primary Topic | Whole Body |
| Secondary Topic | Cancer |
| Model | Mouse |
| Tertiary Topic | Novel Therapy |
| Vehicle | Gas (Sustained Release) |
| pH | N/A |
| Application | Injection |
| Comparison | |
| Complement | Photothermal Therapy (PTT) |